Clinical Trial Update: Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing busulfan-fludarabine versus thiotepa-fludarabine regimens in allogeneic transplantation for myelofibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Busulfan-fludarabine
• Thiotepa-fludarabine

Snippet

Sponsor: Gruppo Italiano Trapianto di Midollo Osseo | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED